Veterinary service provider CVS Equine has revealed it is carrying out a research project investigating the relative success of treatment options for Equine Glandular Gastric Disease (EGGD).
Currently, there is limited understanding of the causes of EGGD and treatment responses can vary widely between individuals making it challenging to treat. Many horses undergo a trial‑and‑error approach before the right management and medication combination is found.
The aim of the study, which is being led by Ewan Macaulay, senior veterinary surgeon at Alnorthumbria Equine Vets and RCVS Advanced Practitioner in Equine Internal Medicine, is to address this evidence gap by evaluating the effectiveness of the range of treatment protocols currently used in first‑opinion practice.
‘Lack robust evidence’
“We’re fortunate to have a growing awareness of equine glandular gastric disease, but we still lack robust evidence on which treatment strategies offer the best outcomes,” said Ewan.
“By capturing detailed clinical data from naturally occurring cases across multiple practices, we aim to build a clearer picture of what works – and why. Ultimately, our goal is to improve treatment success and welfare for affected horses.”
Who’s eligible
Any horse over one year of age undergoing gastroscopy at select CVS Equine practices is eligible for inclusion.
Vets are encouraged to perform an optional pre-gastroscopy clinical and orthopaedic assessment, including trot‑up, flexion tests, lunging, and palpation of the neck, back and hindquarters. The aim is to capture any musculoskeletal discomfort that could act as a stressor contributing to glandular ulceration.
Gastroscopy is then performed as usual, with participating clinicians submitting videos or images alongside standardised record sheets. Horses are treated exactly as they would be during routine clinical care – the choice of therapy remains entirely at the discretion of the attending veterinary surgeon, ensuring the study reflects genuine clinical decision‑making across multiple practices.
Follow‑up examinations and repeat gastroscopy findings are captured at each re‑evaluation, typically around four weeks after initial diagnosis. Owners complete a short survey after each gastroscopy and a final follow‑up survey three months after the last examination. All data and imagery are anonymised prior to analysis.
Funding
The study has received funding from the CVS Brian Pound Grant, an inaugural grant programme which honours Brian Pound, CVS founder and passionate advocate for research and quality improvement across the profession.
Participating vets and owners will be entered into a prize draw to win a gift voucher.
Image © CVS Equine.
